Letter to the Editor: EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer
Saved in:
| Main Authors: | Hinpetch Daungsupawong PhD, Viroj Wiwanitkit MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-10-01
|
| Series: | Technology in Cancer Research & Treatment |
| Online Access: | https://doi.org/10.1177/15330338241292706 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Letter to the editor: Validation of the visual body image classification in adolescent idiopathic scoliosis
by: Hinpetch Daungsupawong, et al.
Published: (2025-02-01) -
Revolutionizing NSCLC Treatment: Immunotherapy Strategies for EGFR‐TKIs Resistance
by: Jin Tian, et al.
Published: (2024-12-01) -
Letter to editor regarding the article ‘Prediction of heart failure events based on physiologic sensor data’
by: Hinpetch Daungsupawong, et al.
Published: (2025-02-01) -
Expert consensus on the use of third-generation EGFR-TKIs in EGFR-mutated advanced non-small cell lung cancer with various T790M mutations post-resistance to first-/second-generation EGFR-TKIs
by: Jietao Ma, et al.
Published: (2024-10-01) -
Profiling of driver mutations in lung adenocarcinoma patients identifies rare compound EGFR mutations sensitive to second-generation EGFR-TKIs
by: Jun Li, et al.
Published: (2024-12-01)